Complementary, holistic, and integrative medicine: Crohn disease.
1Pediatric Gastroenterology, Atlantic Health, Morristown Memorial Hospital, Morristown, NJ, USA.
Complementary and alternative medicine (CAM) use is common in pediatric Crohn's disease (CD), but high-quality research is lacking. Healthcare providers should discuss CAM with patients, prioritizing safety and integration with conventional treatments.
Area of Science:
- Pediatric Gastroenterology
- Integrative Medicine
- Complementary and Alternative Medicine (CAM)
Background:
- Complementary and alternative medicine (CAM) is frequently used by children with Crohn's disease (CD).
- There is a significant gap in high-quality, evidence-based research on CAM efficacy and safety in this population.
- Pediatric CD can lead to growth failure and necessitate surgical intervention, highlighting the need for careful treatment considerations.
Purpose of the Study:
- To review the current evidence regarding CAM use in pediatric CD.
- To emphasize the need for rigorous research, including randomized controlled trials.
- To highlight the importance of integrating biobehavioral approaches and safe CAM therapies into conventional care.
Main Methods:
- Literature review of existing studies on CAM in pediatric CD.
- Analysis of the role of psychosocial distress and biobehavioral interventions.
- Discussion of safety, efficacy, and drug-supplement interactions of CAM therapies.
Main Results:
- Limited high-quality evidence supports the use of most CAM therapies in pediatric CD.
- Psychosocial distress is a significant factor that warrants attention through biobehavioral techniques.
- Non-harmful CAM therapies may be considered as adjuncts to conventional medical treatment.
Conclusions:
- Further randomized controlled trials are essential to establish evidence-based guidelines for CAM in pediatric CD.
- Healthcare providers must actively inquire about CAM use, assess its safety and efficacy, and manage potential interactions.
- A collaborative approach between providers and patients is crucial for optimizing care in pediatric CD.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...


